UNSPSC 85871116: Computerized tomography (ct scan) of sella turcica/pituitary gland using high osmolar contrast

This classification denotes the group of activities that yields a imaging intervention or procedure to computerized tomography (ct scan) of sella turcica/pituitary gland using high osmolar contrast. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code B0290ZZ

UNSPSC 85871116 Computerized tomography (ct scan) of sella turcica/pituitary gland using high osmolar contrast is a Commodity code that shows limited alignment between its nominal scope and recent state and local procurement activity. The recent opportunities tagged under this code do not reflect medical imaging services or CT scan procedures at all. Instead, the opportunities cover diagnostic imaging system infrastructure (a PACS platform implementation), special education contracted services (speech therapists, occupational therapists, audiologists, and related specialists), and temporary health professional staffing across ancillary clinical categories including diagnostic imaging and radiology. The code appears to have been applied inconsistently or incorrectly to these solicitations; none of them solicit the specific neuroimaging procedure the code names.

The three recent opportunities originate from different issuing bodies across California and Texas: San Mateo Medical Center (a county public hospital system in California) issued an RFP for enterprise PACS implementation due October 21, 2026; the County of Santa Clara Health System issued an RFQ for temporary health professional staffing including diagnostic imaging and radiology technicians, with a proposal deadline of October 7, 2026; and Birdville Independent School District in northeast Tarrant County, Texas, issued a competitive sealed proposal request for special education contracted services due October 21, 2026. The code shows little relevant recent activity for the specialized neuroimaging service its name describes, making it difficult to characterize current market demand or issuing-body patterns under the intended scope.